116 related articles for article (PubMed ID: 16504834)
1. Anthropometric features and cardiovascular risk in young Latin Americans with type 2 diabetes mellitus.
Avilés-Santa L; Salinas K; Adams-Huet B; Raskin P
J Diabetes Complications; 2006; 20(2):69-74. PubMed ID: 16504834
[TBL] [Abstract][Full Text] [Related]
2. Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus.
Avilés-Santa L; Salinas K; Adams-Huet B; Raskin P
J Investig Med; 2006 Jan; 54(1):20-31. PubMed ID: 16409887
[TBL] [Abstract][Full Text] [Related]
3. Assessment of cardiovascular risk in adults with type 2 diabetes and metabolic syndrome: Framingham versus UKPDS equations.
Kim CJ; Kang HS; Schlenk EA; Chae SM
Diabetes Educ; 2015 Apr; 41(2):203-13. PubMed ID: 25699567
[TBL] [Abstract][Full Text] [Related]
4. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
[TBL] [Abstract][Full Text] [Related]
5. Effects of multiple daily insulin injections on peripheral glucose disposal in Latin Americans with type 2 diabetes mellitus.
Avilés-Santa L; Salinas K; Adams-Huet B; Raskin P
J Investig Med; 2007 Jan; 55(1):11-7. PubMed ID: 17441407
[TBL] [Abstract][Full Text] [Related]
6. Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk.
Jarmul JA; Pignone M; Pletcher MJ
Circ Cardiovasc Qual Outcomes; 2015 Sep; 8(5):501-7. PubMed ID: 26349840
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
8. Potentially modifiable metabolic factors and the risk of cardiovascular disease hospitalizations in urban African Americans with diabetes.
Cook CB; Hentz JG; Tsui C; Ziemer DC; Naylor DB; Miller WJ
Ethn Dis; 2006; 16(4):852-8. PubMed ID: 17061737
[TBL] [Abstract][Full Text] [Related]
9. Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America.
Aschner P; Ruiz A; Balkau B; Massien C; Haffner SM;
J Clin Hypertens (Greenwich); 2009 Dec; 11(12):769-74. PubMed ID: 20021540
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of FRAMINGHAM, PROCAM and SCORE models in Turkish people with Type 2 diabetes: comparison of three cardiovascular risk calculations.
Bayındır Çevik A; Özcan Ş; Satman İ
Contemp Nurse; 2015; 50(2-3):183-95. PubMed ID: 26503421
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States.
Daviglus ML; Talavera GA; Avilés-Santa ML; Allison M; Cai J; Criqui MH; Gellman M; Giachello AL; Gouskova N; Kaplan RC; LaVange L; Penedo F; Perreira K; Pirzada A; Schneiderman N; Wassertheil-Smoller S; Sorlie PD; Stamler J
JAMA; 2012 Nov; 308(17):1775-84. PubMed ID: 23117778
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.
Gaillard TR; Schuster DP; Osei K
Ethn Dis; 1998; 8(3):319-30. PubMed ID: 9926902
[TBL] [Abstract][Full Text] [Related]
13. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.
Wendel CS; Shah JH; Duckworth WC; Hoffman RM; Mohler MJ; Murata GH
BMC Health Serv Res; 2006 May; 6():58. PubMed ID: 16716235
[TBL] [Abstract][Full Text] [Related]
14. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005-2006.
Ackermann RT; Cheng YJ; Williamson DF; Gregg EW
Am J Prev Med; 2011 Jan; 40(1):11-7. PubMed ID: 21146762
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk in Hispanic American women.
Hu J; Amirehsani KA; McCoy TP; Coley SL; Wallace DC
Women Health; 2021; 61(5):395-407. PubMed ID: 33941048
[TBL] [Abstract][Full Text] [Related]
16. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
Wei M; Gaskill SP; Haffner SM; Stern MP
Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614
[TBL] [Abstract][Full Text] [Related]
17. Association of vitamin D status and the risk of cardiovascular disease as assessed by various cardiovascular risk scoring systems in patients with type 2 diabetes mellitus.
Sivritepe R; Basat S; Ortaboz D
Aging Male; 2019 Jun; 22(2):156-162. PubMed ID: 30193547
[TBL] [Abstract][Full Text] [Related]
18. Differential impact of cardiovascular disease (CVD) risk factor clustering on CVD and renal disease among African-American and white patients with type 2 diabetes mellitus.
Summerson JH; Bell RA; Konen JC; Spangler JG
Ethn Dis; 2002; 12(4):530-4. PubMed ID: 12477139
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Meis SB; Schuster D; Gaillard T; Osei K
Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
[TBL] [Abstract][Full Text] [Related]
20. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Reed ML; Kurth T; Fanning KM; Buse DC
Headache; 2017 Nov; 57(10):1507-1521. PubMed ID: 28990165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
